Impact of Inflammation on Adult Prostate Stem Cells
炎症对成体前列腺干细胞的影响
基本信息
- 批准号:10218167
- 负责人:
- 金额:$ 59.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AdultAndrogen ReceptorAntibodiesAutomobile DrivingBenign Prostatic HypertrophyCell Differentiation processCell ProliferationCellsCharacteristicsChronicCritical PathwaysDataData ReportingDevelopmentEpithelialEpithelial Cell ProliferationEpithelial CellsFoundationsGene ActivationGene ExpressionGene Expression ProfileGenesGenetic TranscriptionGrowthGrowth FactorHomeostasisHyperplasiaIL1R1 geneInflammationInflammation MediatorsInterleukin-1Interleukin-1 alphaLaboratoriesLinkMolecularMusNatural regenerationNuclearOrganoidsPathway interactionsPhosphorylationPhosphorylation SiteProstateProstatic hypertrophyRecombinantsRegulationReportingRoleS-Phase FractionSignal TransductionStromal CellsStructure of capsule of prostateTestingTissuesWorkYin-Yanganakinraautocrinebasecell growthcytokinegenetic signaturein vivoinhibitor/antagonistmorphogensnovelnovel strategiesprogenitorprostate enlargementreceptor expressionreceptor functionrepairedself-renewalstem cell expansionstem cell proliferationstem cells
项目摘要
Benign prostatic hyperplasia (BPH) is defined by the expansion of both epithelial and stromal cells within the
transition zone of the prostate. Although there is greater expansion of stromal cells in early BPH, epithelial
hyperplasia is a significant contributor to larger symptomatic BPH prostates. While numerous studies have linked
chronic and recalcitrant inflammation to the development of BPH, the mechanisms by which inflammation leads
to cellular proliferation and hyperplasia are unclear. It is known that inflammation produces a microenvironment
rich in cytokines, growth factors, and other morphogens that promote proliferation of prostate epithelial cells,
including basal prostate stem cells (bPSC). The regulatory mechanisms that control and limit inflammation-
induced epithelial cell proliferation under normal homeostatic conditions are not well defined and represent a
significant deficit in understanding the potential link between inflammation, uncontrolled cellular growth and
prostate enlargement. Data reported herein identify pathways controlling prostate epithelial cell expansion and
form the foundation for proposed studies to better define the regulation of inflammation-induced prostate
epithelial cell proliferation that leads to hyperplasia. Understanding the pathways involved in inflammation-
induced cellular expansion will provide a foundation for the development of novel approaches to block
uncontrolled epithelial growth.
Adult basal prostate stem cells (bPSC) are specialized cells that maintain and repair the cellular integrity of
the prostate; however, studies describing the effect of inflammation on adult bPSC are limited. Previous data
from our laboratories show that inflammation stimulates bPSC expansion and generates basal and luminal
epithelial hyperplasia in vivo as well as larger organoids compared to non-inflamed (naïve) bPSC ex vivo,
demonstrating a sustained proliferative effect on these cells. Given that inflammation drives a bPSC to luminal
cell transition, which requires androgen receptor (AR) and the data reported herein that inflammation stabilizes
AR via phosphorylation and IL-1α and its naturally occurring inhibitor, IL-1ra, where IL-1α inhibits AR expression
and IL1ra enhances expression leading to bPSC-driven expansion of epithelial cells. Based on these data, we
hypothesize that inflammation drives AR stabilization that drives bPSC expansion and epithelial
hyperplasia in BPH. To test the hypothesis we propose to define the molecular basis for inflammation induced
AR stabilization, evaluate pathway impact using novel genetically modified mice and define AR-dependent
programmatic changes in bPSC linked both to proliferation and epithelial hyperplasia.
良性前列腺增生(BPH)是指前列腺内上皮细胞和间质细胞的增生
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy L. Ratliff其他文献
Elevated Cyclic Adenosine 3′, 5′ Monophosphate Enhances Lactic Acid Production by <em>Streptococcus lactis</em>
- DOI:
10.3168/jds.s0022-0302(81)82584-2 - 发表时间:
1981-03-01 - 期刊:
- 影响因子:
- 作者:
Timothy L. Ratliff;Dwight E. Talburt - 通讯作者:
Dwight E. Talburt
1861: Involvement of Growth Factors in the Process of Post-Vasectomy Micro-Recanalization
- DOI:
10.1016/s0022-5347(18)32034-2 - 发表时间:
2007-04-01 - 期刊:
- 影响因子:
- 作者:
Brandon C. Stahl;Timothy L. Ratliff;Barry R. De Young;Moshe Wald - 通讯作者:
Moshe Wald
Comparison of viral vectors: gene transfer efficiency and tissue specificity in a bladder cancer model.
病毒载体的比较:膀胱癌模型中的基因转移效率和组织特异性。
- DOI:
- 发表时间:
2003 - 期刊:
- 影响因子:6.6
- 作者:
D. Siemens;S. Crist;J. Austin;J. Tartaglia;Timothy L. Ratliff - 通讯作者:
Timothy L. Ratliff
UROLOGICAL SURVEYUro-Science
泌尿科检查Uro-Science
- DOI:
- 发表时间:
2004 - 期刊:
- 影响因子:0
- 作者:
Timothy L. Ratliff - 通讯作者:
Timothy L. Ratliff
Suppressive Effects of Regional Lymph Node Cells and Extracts on Antibody-Dependent Cellular Cytotoxicity
- DOI:
10.1016/s0022-5347(17)57501-1 - 发表时间:
1978-03-01 - 期刊:
- 影响因子:
- 作者:
William J. Catalona;Arlene T. Feldman;Timothy L. Ratliff;Robert E. Mccool - 通讯作者:
Robert E. Mccool
Timothy L. Ratliff的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy L. Ratliff', 18)}}的其他基金
T cell regulation by adult prostate stem cells
成体前列腺干细胞对 T 细胞的调节
- 批准号:
10382302 - 财政年份:2021
- 资助金额:
$ 59.47万 - 项目类别:
Impact of Inflammation on Adult Prostate Stem Cells
炎症对成体前列腺干细胞的影响
- 批准号:
10439754 - 财政年份:2020
- 资助金额:
$ 59.47万 - 项目类别:
Impact of Inflammation on Adult Prostate Stem Cells
炎症对成体前列腺干细胞的影响
- 批准号:
10655549 - 财政年份:2020
- 资助金额:
$ 59.47万 - 项目类别:
Use of Micro-RNA Arrays to Identify MDSC Functional Pathways and Markers
使用 Micro-RNA 阵列识别 MDSC 功能途径和标记
- 批准号:
8451031 - 财政年份:2013
- 资助金额:
$ 59.47万 - 项目类别:
Use of Micro-RNA Arrays to Identify MDSC Functional Pathways and Markers
使用 Micro-RNA 阵列识别 MDSC 功能途径和标记
- 批准号:
8601921 - 财政年份:2013
- 资助金额:
$ 59.47万 - 项目类别:
Inflammation and Prostate Cancer Development and Progression
炎症与前列腺癌的发生和进展
- 批准号:
8096809 - 财政年份:2010
- 资助金额:
$ 59.47万 - 项目类别:
Inflammation and Prostate Cancer Development and Progression
炎症与前列腺癌的发生和进展
- 批准号:
8009233 - 财政年份:2010
- 资助金额:
$ 59.47万 - 项目类别:
相似海外基金
Androgen receptor: A master regulator of lipid metabolism
雄激素受体:脂质代谢的主要调节因子
- 批准号:
DP230103210 - 财政年份:2023
- 资助金额:
$ 59.47万 - 项目类别:
Discovery Projects
Regulation of androgen receptor signaling in prostate cancer by protein arginine methylation
通过蛋白质精氨酸甲基化调节前列腺癌中的雄激素受体信号传导
- 批准号:
10584689 - 财政年份:2023
- 资助金额:
$ 59.47万 - 项目类别:
Structural and functional analysis of a novel class of androgen receptor antagonists
一类新型雄激素受体拮抗剂的结构和功能分析
- 批准号:
10650956 - 财政年份:2023
- 资助金额:
$ 59.47万 - 项目类别:
Role of the Androgen Receptor in Insulin Secretion in the Male
雄激素受体在男性胰岛素分泌中的作用
- 批准号:
10488954 - 财政年份:2023
- 资助金额:
$ 59.47万 - 项目类别:
Targeting tumor cell macrophage lipid interactions to overcome resistance to androgen receptor targeted therapy
靶向肿瘤细胞巨噬细胞脂质相互作用以克服对雄激素受体靶向治疗的耐药性
- 批准号:
10651105 - 财政年份:2023
- 资助金额:
$ 59.47万 - 项目类别:
Preclinical development of ONCT-505, an Androgen Receptor Antagonist and Degrader, as new potential therapeutic for Kennedy's Disease
ONCT-505(一种雄激素受体拮抗剂和降解剂)的临床前开发,作为肯尼迪病的新潜在治疗方法
- 批准号:
10603636 - 财政年份:2023
- 资助金额:
$ 59.47万 - 项目类别:
Proliferating cell nuclear antigen in regulation of androgen receptor signalings in castration-resistant prostate cancer cells
增殖细胞核抗原对去势抵抗性前列腺癌细胞雄激素受体信号传导的调节
- 批准号:
10544062 - 财政年份:2022
- 资助金额:
$ 59.47万 - 项目类别:
Effects of androgen receptor (AR) signaling on CD4+ T cell metabolism during airway inflammation
气道炎症期间雄激素受体 (AR) 信号对 CD4 T 细胞代谢的影响
- 批准号:
10534943 - 财政年份:2022
- 资助金额:
$ 59.47万 - 项目类别:
TITLE: BLADDER CANCER CHEMOPREVENTION USING THE ANDROGEN RECEPTOR INHIBITOR APALUTAMIDE
标题:使用雄激素受体抑制剂阿帕鲁胺进行膀胱癌化学预防
- 批准号:
10677989 - 财政年份:2022
- 资助金额:
$ 59.47万 - 项目类别:














{{item.name}}会员




